The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction

By Menyar Ayman   Altamimi O.   Gomaa Mohamed   Fawzy Zainab   Rahman M.   Bener Abdulbari  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 235-240

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of Number of Days in Culture and Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Genotype on PAI-1 Antigen Release by Cultured Human Umbilical Vein Endothelial Cells - Identification by morphologic and immunologic criteria

By McCormack L.J.   Semple J.I.   Stickland M.H.   Barrett J.H.   Grant P.J.  

Thrombosis Research, Vol. 92, Iss. 5, 1998-12 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

The Effect of Anticonvulsant Drugs on the Fibrinolytic Activity of Tissue Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 25, Iss. 1-2, 2007-12 ,pp. : 107-110

Karger

Access to resources Recommend Favorite

Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

By Sales MF   Sóter MO   Candido AL   Fernandes AP   Oliveira FR   Ferreira ACS   Sousa MO   Ferreira CN   Gomes KB  

Gynecological Endocrinology, Vol. 29, Iss. 10, 2013-10 ,pp. : 936-939

Informa Healthcare

Access to resources Recommend Favorite

Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study

By Ponthieux A.   Herbeth B.   Droesch S.   Haddy N.   Lambert D.   Visvikis S.  

Atherosclerosis, Vol. 172, Iss. 2, 2004-02 ,pp. : 299-308

Elsevier

Access to resources Recommend Favorite